selenium nanoparticles

Overview

Selenium nanoparticles (SeNPs) are nanoscale elemental selenium structures, typically ranging from a few to several hundred nanometers in diameter, that have emerged as a versatile platform in biomedical, pharmaceutical, and materials science research. Unlike bulk selenium or inorganic selenium salts, SeNPs offer substantially improved biocompatibility and a markedly reduced toxicity profile, making them attractive candidates for therapeutic delivery, antioxidant supplementation, and antimicrobial applications. Selenium is an essential trace element whose biological activity is primarily mediated through selenoproteins—enzymes such as thioredoxin reductase (TrxR1) and glutathione peroxidase (GPX4) that regulate cellular redox homeostasis and protect against oxidative stress. At the nanoscale, selenium retains and can amplify these antioxidant properties while gaining new surface characteristics that facilitate functionalization, drug loading, and targeted delivery.

The synthesis of SeNPs is achievable through chemical reduction, biogenic (green) methods using plant extracts or microbial agents, and in situ fabrication within polymer matrices. Green synthesis routes, which employ phytochemical reducing and stabilizing agents, have gained particular traction due to their environmental compatibility and the additional bioactive coating they confer on the nanoparticle surface. Once synthesized, SeNPs can be further functionalized with polymers such as sodium alginate, chitosan, or albumin to modulate stability, surface charge, and targeting behavior. Their multifunctional nature—combining antioxidant, anti-inflammatory, antimicrobial, and drug-delivery capabilities—positions SeNPs at the intersection of several rapidly advancing fields in nanomedicine.

Recent Publications Summary

Recent studies have focused on selenium nanoparticles (SeNPs) as a versatile platform for antioxidant, anti-inflammatory, antimicrobial, and tissue-protective applications. Several reports used green synthesis approaches with plant extracts or bioactive compounds, including Rhodiola, olive leaf, Catharanthus roseus, Trachyspermum ammi, and resveratrol, to generate SeNPs with defined physicochemical properties and biological activity 42335449Jun42143081May42049942Apr41891280Mar42159899May. Characterization commonly included UV-visible spectroscopy, transmission electron microscopy, FTIR, SEM, XRD, zeta potential, and related analyses, confirming nanoscale size, morphology, and surface features relevant to bioactivity 42143081May42049942Apr41891280Mar.

In preclinical disease models, SeNPs were reported to mitigate oxidative stress and inflammation. Rhodiola-derived SeNPs protected mice and hematopoietic stem cells from 60Co γ-ray-induced injury, with improved hematopoietic function, survival, and reduced mitochondrial oxidative damage 42335449Jun. In a silicosis mouse model, selenium nanoparticle-enhanced resveratrol more effectively than resveratrol-loaded solid lipid nanoparticle suppressed pulmonary inflammation and fibrogenesis, reducing oxidative stress, collagen deposition, and activation of inflammatory and fibrotic signaling pathways 42159899May. In goats with Klebsiella pneumoniae-induced mastitis, oral SeNPs reduced histopathological damage and neutrophil infiltration, restored anti-inflammatory markers, enhanced glutathione-related defenses, and suppressed ferroptosis through the PRDX6/SEPHS2/GPX4 axis 41780848Mar. In diabetic periodontitis, a selenium-albumin corona rinse outperformed commercial SeNPs in anti-inflammatory and antibacterial effects and improved osteogenesis via the TrxR1/ROS/β-catenin cascade 41207151Nov.

Antimicrobial and antibiofilm activity was also a recurring theme. Olive leaf-derived SeNPs showed broad antimicrobial effects against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, and Candida albicans, with strong inhibition of C. albicans biofilm formation 42143081May. Catharanthus roseus-mediated SeNPs likewise demonstrated broad-spectrum antimicrobial activity and antiviral activity against adenovirus, alongside cytotoxicity against HepG2 cells 42049942Apr. In food-related applications, curcumin-selenium nanoparticles encapsulated in sodium alginate-chitosan hydrogel beads provided sustained antioxidant and antibacterial protection in edible oils, reducing oxidation indices in soybean and rapeseed oil 41806650Mar.

SeNPs have also been explored in translational and materials-based settings. In a pilot randomized clinical trial in sepsis patients with immune dysfunction, adjunctive SeNP supplementation improved lymphocyte counts and T-cell subsets and was associated with reduced inflammation 41825095Mar. For hemodialysis, in situ engineered SeNPs incorporated into PLA/PEG mixed-matrix membranes improved hydrophilicity, antifouling behavior, creatinine clearance, and blood-compatible filtration performance 42093444May. Across these studies, SeNPs were repeatedly positioned as a multifunctional nanomaterial whose therapeutic effects were linked to antioxidant activity, modulation of inflammatory pathways, and improved compatibility with biological systems 42335449Jun42159899May41825095Mar42093444May.

What Changes, What Holds

1. SeNPs now look like a broadly tunable bioactive platform rather than just a generic antioxidant nanomaterial
REINFORCES The new work strengthens the baseline view that these particles are versatile and readily functionalized, while showing that green synthesis can reliably yield biologically active SeNPs from a wider range of plant and phytochemical sources. It does not change the core account, but it sharpens the practical message: surface chemistry and synthesis route remain central determinants of activity and should be treated as part of the therapeutic design, not just the manufacturing step 42335449Jun42143081May.

2. SeNPs are extending from general redox protection into disease-specific anti-inflammatory and anti-fibrotic mechanisms
NEW DIRECTION The baseline already frames SeNPs as antioxidant and anti-inflammatory, but these studies move the entity into more specific tissue-protective roles, including radiation injury, silicosis, mastitis, and periodontal disease. That broadens the account rather than overturning it, and it suggests the key question is not whether SeNPs reduce oxidative stress, but which downstream pathways they can modulate in different organs. The evidence is still preclinical, so mechanism and translatability remain unsettled 42335449Jun42159899May.

3. SeNPs are emerging as direct antimicrobial and antibiofilm agents with formulation-dependent performance
REINFORCES These findings fit squarely within the established antimicrobial promise of SeNPs and make that claim more concrete by showing activity against bacteria, fungi, and biofilms, plus utility in food preservation. The main addition is not a new role but a clearer sense that delivery format matters: hydrogel or bead encapsulation can preserve antioxidant and antibacterial function over time. Nothing here displaces the baseline; it simply strengthens the case that antimicrobial use is a real, not merely theoretical, application 42143081May41806650Mar.

4. SeNPs are moving into clinical and membrane-engineering settings, but the human evidence remains early
NEW DIRECTION The baseline discusses biomedical and materials research in general terms, and this work shows those ideas reaching a pilot trial in sepsis and a hemodialysis membrane application. That expands the entity’s scope beyond preclinical delivery and supplementation, yet it does not establish routine clinical use. The sepsis signal is preliminary and the membrane data are engineering-focused, so both need larger, controlled studies before they can alter practice 41825095Mar42093444May.

Overview update candidates: disease-specific anti-inflammatory and anti-fibrotic mechanisms; direct clinical and membrane-engineering applications; formulation-dependent antimicrobial and food-preservation uses.